Therapy: Avoiding treatment failures associated with HCV resistance.
National Reference Center for Viral Hepatitis B, C and D, Department of Virology, and INSERM U955, Hôpital Henri Mondor, Université Paris-Est, 51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France.
Jean-Michel
JM
Pawlotsky
D024882:Drug Resistance, Viral; D016174:Hepacivirus / Q000187:drug effects*; D006526:Hepatitis C / Q000188:drug therapy; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D017211:Treatment Failure